Cargando…

Ventricular Tachycardia Has Mainly Non-Ischaemic Substrates in Patients with Autoimmune Rheumatic Diseases and a Preserved Ejection Fraction

Non-sustained ventricular tachycardia (NSVT) is a potentially lethal arrhythmia that is most commonly attributed to coronary artery disease. We hypothesised that among patients with NSVT and preserved ejection fraction, cardiovascular magnetic resonance (CMR) would identify a different proportion of...

Descripción completa

Detalles Bibliográficos
Autores principales: Markousis-Mavrogenis, George, Poulos, George, Dimitroulas, Theodoros, Giannakopoulou, Aikaterini, Mavragani, Clio, Vartela, Vasiliki, Manolopoulou, Dionysia, Kolovou, Genovefa, Voulgari, Paraskevi, Sfikakis, Petros P., Kitas, George D., Mavrogeni, Sophie I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001227/
https://www.ncbi.nlm.nih.gov/pubmed/33804066
http://dx.doi.org/10.3390/diagnostics11030519
_version_ 1783671180688883712
author Markousis-Mavrogenis, George
Poulos, George
Dimitroulas, Theodoros
Giannakopoulou, Aikaterini
Mavragani, Clio
Vartela, Vasiliki
Manolopoulou, Dionysia
Kolovou, Genovefa
Voulgari, Paraskevi
Sfikakis, Petros P.
Kitas, George D.
Mavrogeni, Sophie I.
author_facet Markousis-Mavrogenis, George
Poulos, George
Dimitroulas, Theodoros
Giannakopoulou, Aikaterini
Mavragani, Clio
Vartela, Vasiliki
Manolopoulou, Dionysia
Kolovou, Genovefa
Voulgari, Paraskevi
Sfikakis, Petros P.
Kitas, George D.
Mavrogeni, Sophie I.
author_sort Markousis-Mavrogenis, George
collection PubMed
description Non-sustained ventricular tachycardia (NSVT) is a potentially lethal arrhythmia that is most commonly attributed to coronary artery disease. We hypothesised that among patients with NSVT and preserved ejection fraction, cardiovascular magnetic resonance (CMR) would identify a different proportion of ischaemic/non-ischaemic arrhythmogenic substrates in those with and without autoimmune rheumatic diseases (ARDs). In total, 80 consecutive patients (40 with ARDs, 40 with non-ARD-related cardiac pathology) with NSVT in the past 15 days and preserved left ventricular ejection fraction were examined using a 1.5-T system. Evaluated parameters included biventricular volumes/ejection fractions, T2 signal ratio, early/late gadolinium enhancement (EGE/LGE), T1 and T2 mapping and extracellular volume fraction (ECV). Mean age did not differ across groups, but patients with ARDs were more often women (32 (80%) vs. 15 (38%), p < 0.001). Biventricular systolic function, T2 signal ratio and EGE and LGE extent did not differ significantly between groups. Patients with ARDs had significantly higher median native T1 mapping (1078.5 (1049.0–1149.0) vs. 1041.5 (1014.0–1079.5), p = 0.003), higher ECV (31.0 (29.0–32.0) vs. 28.0 (26.5–30.0), p = 0.003) and higher T2 mapping (57.5 (54.0–61.0) vs. 52.0 (48.0–55.5), p = 0.001). In patients with ARDs, the distribution of cardiac fibrosis followed a predominantly non-ischaemic pattern, with ischaemic patterns being more common in those without ARDs (p < 0.001). After accounting for age and cardiovascular comorbidities, most findings remained unaffected, while only tissue characterisation indices remained significant after additionally correcting for sex. Patients with ARDs had a predominantly non-ischaemic myocardial scar pattern and showed evidence of diffuse inflammatory/ischaemic changes (elevated native T1-/T2-mapping and ECV values) independent of confounding factors.
format Online
Article
Text
id pubmed-8001227
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-80012272021-03-28 Ventricular Tachycardia Has Mainly Non-Ischaemic Substrates in Patients with Autoimmune Rheumatic Diseases and a Preserved Ejection Fraction Markousis-Mavrogenis, George Poulos, George Dimitroulas, Theodoros Giannakopoulou, Aikaterini Mavragani, Clio Vartela, Vasiliki Manolopoulou, Dionysia Kolovou, Genovefa Voulgari, Paraskevi Sfikakis, Petros P. Kitas, George D. Mavrogeni, Sophie I. Diagnostics (Basel) Article Non-sustained ventricular tachycardia (NSVT) is a potentially lethal arrhythmia that is most commonly attributed to coronary artery disease. We hypothesised that among patients with NSVT and preserved ejection fraction, cardiovascular magnetic resonance (CMR) would identify a different proportion of ischaemic/non-ischaemic arrhythmogenic substrates in those with and without autoimmune rheumatic diseases (ARDs). In total, 80 consecutive patients (40 with ARDs, 40 with non-ARD-related cardiac pathology) with NSVT in the past 15 days and preserved left ventricular ejection fraction were examined using a 1.5-T system. Evaluated parameters included biventricular volumes/ejection fractions, T2 signal ratio, early/late gadolinium enhancement (EGE/LGE), T1 and T2 mapping and extracellular volume fraction (ECV). Mean age did not differ across groups, but patients with ARDs were more often women (32 (80%) vs. 15 (38%), p < 0.001). Biventricular systolic function, T2 signal ratio and EGE and LGE extent did not differ significantly between groups. Patients with ARDs had significantly higher median native T1 mapping (1078.5 (1049.0–1149.0) vs. 1041.5 (1014.0–1079.5), p = 0.003), higher ECV (31.0 (29.0–32.0) vs. 28.0 (26.5–30.0), p = 0.003) and higher T2 mapping (57.5 (54.0–61.0) vs. 52.0 (48.0–55.5), p = 0.001). In patients with ARDs, the distribution of cardiac fibrosis followed a predominantly non-ischaemic pattern, with ischaemic patterns being more common in those without ARDs (p < 0.001). After accounting for age and cardiovascular comorbidities, most findings remained unaffected, while only tissue characterisation indices remained significant after additionally correcting for sex. Patients with ARDs had a predominantly non-ischaemic myocardial scar pattern and showed evidence of diffuse inflammatory/ischaemic changes (elevated native T1-/T2-mapping and ECV values) independent of confounding factors. MDPI 2021-03-15 /pmc/articles/PMC8001227/ /pubmed/33804066 http://dx.doi.org/10.3390/diagnostics11030519 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ).
spellingShingle Article
Markousis-Mavrogenis, George
Poulos, George
Dimitroulas, Theodoros
Giannakopoulou, Aikaterini
Mavragani, Clio
Vartela, Vasiliki
Manolopoulou, Dionysia
Kolovou, Genovefa
Voulgari, Paraskevi
Sfikakis, Petros P.
Kitas, George D.
Mavrogeni, Sophie I.
Ventricular Tachycardia Has Mainly Non-Ischaemic Substrates in Patients with Autoimmune Rheumatic Diseases and a Preserved Ejection Fraction
title Ventricular Tachycardia Has Mainly Non-Ischaemic Substrates in Patients with Autoimmune Rheumatic Diseases and a Preserved Ejection Fraction
title_full Ventricular Tachycardia Has Mainly Non-Ischaemic Substrates in Patients with Autoimmune Rheumatic Diseases and a Preserved Ejection Fraction
title_fullStr Ventricular Tachycardia Has Mainly Non-Ischaemic Substrates in Patients with Autoimmune Rheumatic Diseases and a Preserved Ejection Fraction
title_full_unstemmed Ventricular Tachycardia Has Mainly Non-Ischaemic Substrates in Patients with Autoimmune Rheumatic Diseases and a Preserved Ejection Fraction
title_short Ventricular Tachycardia Has Mainly Non-Ischaemic Substrates in Patients with Autoimmune Rheumatic Diseases and a Preserved Ejection Fraction
title_sort ventricular tachycardia has mainly non-ischaemic substrates in patients with autoimmune rheumatic diseases and a preserved ejection fraction
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001227/
https://www.ncbi.nlm.nih.gov/pubmed/33804066
http://dx.doi.org/10.3390/diagnostics11030519
work_keys_str_mv AT markousismavrogenisgeorge ventriculartachycardiahasmainlynonischaemicsubstratesinpatientswithautoimmunerheumaticdiseasesandapreservedejectionfraction
AT poulosgeorge ventriculartachycardiahasmainlynonischaemicsubstratesinpatientswithautoimmunerheumaticdiseasesandapreservedejectionfraction
AT dimitroulastheodoros ventriculartachycardiahasmainlynonischaemicsubstratesinpatientswithautoimmunerheumaticdiseasesandapreservedejectionfraction
AT giannakopoulouaikaterini ventriculartachycardiahasmainlynonischaemicsubstratesinpatientswithautoimmunerheumaticdiseasesandapreservedejectionfraction
AT mavraganiclio ventriculartachycardiahasmainlynonischaemicsubstratesinpatientswithautoimmunerheumaticdiseasesandapreservedejectionfraction
AT vartelavasiliki ventriculartachycardiahasmainlynonischaemicsubstratesinpatientswithautoimmunerheumaticdiseasesandapreservedejectionfraction
AT manolopouloudionysia ventriculartachycardiahasmainlynonischaemicsubstratesinpatientswithautoimmunerheumaticdiseasesandapreservedejectionfraction
AT kolovougenovefa ventriculartachycardiahasmainlynonischaemicsubstratesinpatientswithautoimmunerheumaticdiseasesandapreservedejectionfraction
AT voulgariparaskevi ventriculartachycardiahasmainlynonischaemicsubstratesinpatientswithautoimmunerheumaticdiseasesandapreservedejectionfraction
AT sfikakispetrosp ventriculartachycardiahasmainlynonischaemicsubstratesinpatientswithautoimmunerheumaticdiseasesandapreservedejectionfraction
AT kitasgeorged ventriculartachycardiahasmainlynonischaemicsubstratesinpatientswithautoimmunerheumaticdiseasesandapreservedejectionfraction
AT mavrogenisophiei ventriculartachycardiahasmainlynonischaemicsubstratesinpatientswithautoimmunerheumaticdiseasesandapreservedejectionfraction